Ryvyl Inc FY2025 Q3 Financial Report: Net Loss Decreased 74.7% YoY

Executive Summary

Ryvyl Inc (RVYL) reported its fiscal third quarter of 2025 with a net loss of $13.1 million, representing a 74.7% decrease compared to a net loss of $51.7 million in the same period last year. Revenue remained relatively stable at approximately $2.8 million, down slightly from $2.8 million YoY. The significant reduction in net loss highlights improved operational efficiency and cost management amidst ongoing strategic restructuring. The company’s balance sheet shows a cash position of $1.16 million, with total assets of $23.4 million and liabilities of $26.6 million, including long-term debt of $615,000. Cash flow from operating activities was negative at $6.2 million, primarily due to ongoing investments and restructuring costs. The company continues to face liquidity challenges but is actively pursuing capital raises and strategic M&A opportunities to support its long-term growth. Investors should monitor upcoming liquidity events and the progress of ongoing legal and regulatory proceedings, which pose potential risks to future performance.

Key Metrics

Management Discussion and Analysis (MD&A)

Ryvyl Inc’s Q3 2025 results reflect a strategic shift towards cost containment and liquidity preservation. The company’s revenue remained flat YoY, primarily derived from banking services and payment processing fees following the divestiture of its European operations. The net loss significantly decreased by 74.7%, driven by lower operating expenses, impairment charges, and restructuring costs. Operating expenses declined by approximately 13%, with notable reductions in general and administrative costs. The company’s liquidity position remains tight, with cash and restricted cash totaling $1.16 million, down from $2.6 million in the prior year, due to ongoing investments and debt repayments. The balance sheet shows a substantial decrease in total assets, mainly due to the sale of Ryvyl EU and impairment charges on intangible assets. The company is actively engaged in raising additional capital and exploring strategic M&A to support future growth and liquidity needs. Risks include ongoing legal proceedings, regulatory uncertainties, and market competition, which could impact the company’s financial stability and strategic initiatives.

Income Statement Analysis

Revenue for Q3 2025 was approximately $2.8 million, stable compared to the same period last year. Gross profit increased by 30.7% to $1.4 million, reflecting improved cost controls and operational efficiencies. Operating expenses decreased by 13%, primarily due to lower general and administrative costs and impairment charges. The company reported a net loss of $13.1 million, a substantial improvement from a net loss of $51.7 million in Q3 2024, mainly due to reduced operating costs and impairment expenses. Earnings per share (EPS) on a basic and diluted basis were both negative at $-0.07, consistent with the prior year. The improved net loss trend indicates progress in restructuring efforts, although ongoing liquidity challenges remain a concern for sustained operations.

Balance Sheet Analysis

As of September 30, 2025, Ryvyl Inc’s total assets stood at $23.4 million, down significantly from $122.3 million at the end of 2024, mainly due to the sale of Ryvyl EU and asset impairments. Cash and restricted cash totaled $1.16 million, a decrease of 55.5% YoY, reflecting ongoing operational expenditures and debt repayments. Total liabilities decreased by 78.4% to $26.6 million, primarily due to the repayment of long-term debt and sale of assets. The company’s debt includes a $615,000 long-term obligation, with no current maturities. Stockholders’ equity remains negative at approximately $3.2 million, indicating accumulated deficits. Liquidity remains a key concern, and the company’s ability to meet short-term obligations depends on successful capital raising and strategic initiatives.

Cash Flow Analysis

Cash flows from operating activities were negative at $6.2 million, mainly due to net losses and working capital adjustments. Investing activities used $76,351,000, primarily from the sale of Ryvyl EU and capital expenditures. Financing activities generated $7.35 million, mainly from capital raises and debt proceeds, offset by debt repayments. The company’s free cash flow remains negative, emphasizing the need for additional funding. Management’s focus is on executing capital raises, cost reductions, and strategic M&A to improve liquidity and operational stability.

Ratios & DuPont Analysis

Net margin is negative at -468%, reflecting the net loss relative to revenue. Return on assets (ROA) is approximately -56%, indicating inefficient asset utilization. Return on equity (ROE) is highly negative at -410%, driven by accumulated deficits. Asset turnover is approximately 0.12, and the equity multiplier is 7.3, highlighting leverage risks. The DuPont analysis underscores the need for improved profitability and asset efficiency to achieve sustainable growth.

Risk Factors

Key risks include ongoing legal proceedings, regulatory compliance challenges, liquidity constraints, and market competition. The company’s legal disputes and SEC investigations pose potential financial and reputational risks. Liquidity shortages threaten operational continuity, requiring successful capital raises. Market competition in fintech and payment processing sectors could impact revenue growth. Regulatory uncertainties, especially in licensing and compliance, may lead to additional costs or restrictions. Strategic risks involve execution of M&A and restructuring plans, which are critical for long-term viability.

Notes & Additional Commentary

Unusual items in Q3 2025 include impairment charges on intangible assets totaling $1.1 million and asset sale losses of approximately $6.5 million. The company’s strategic divestitures and asset impairments reflect ongoing restructuring efforts. The sale of Ryvyl EU was completed in June 2025, significantly impacting the balance sheet and operational scope. The company’s liquidity remains tight, with recent capital raises totaling $5.3 million. Legal proceedings, including class actions and SEC investigations, continue to pose risks. Management’s focus remains on liquidity enhancement, cost control, and strategic growth initiatives to restore financial stability.

Investment Implications

While Ryvyl Inc has demonstrated significant progress in reducing net losses and restructuring its operations, liquidity remains a critical concern. The company’s strategic focus on capital raising and M&A could unlock future value but involves execution risks. Investors should monitor upcoming liquidity events, legal proceedings, and regulatory developments. The company’s current valuation reflects high risk but also potential upside if strategic initiatives s쳮d. A balanced approach considering short-term liquidity challenges and long-term growth prospects is recommended.